Menu
← Oncology Approval Tracker
FDA DECISION ·
Opdivo
nivolumab · Bristol Myers Squibb
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Locally advanced or metastatic urothelial carcinoma progressing during or after platinum-containing chemotherapy, or within 12 months of perioperative platinum chemotherapy.
LAMPGEN ANALYSIS
Why it matters
This conversion concerns an established advanced disease indication and is separate from the same-day adjuvant approval.
What research teams should watch
Use the progression date and last platinum dose to classify the applicable prior-treatment interval.
PRIMARY RECORDS